首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Treatment of murine invasive candidiasis with amphotericin B and cilofungin: evidence for enhanced activity with combination therapy.
【2h】

Treatment of murine invasive candidiasis with amphotericin B and cilofungin: evidence for enhanced activity with combination therapy.

机译:用两性霉素B和西洛芬净治疗鼠源性念珠菌病:联合治疗可增强活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The in vivo interactions of cilofungin, an echinocandin antifungal agent, and amphotericin B, a polyene derivative, in a murine model of disseminated candidiasis have been investigated. While single therapy with either drug alone prolonged survival of infected mice, kidney colony counts were not appreciably reduced. In contrast, combination therapy, especially at higher doses of both drugs, resulted in significant prolongation of survival and suppression of growth of yeast cells in the kidneys. Combination therapy of experimental candidiasis with cilofungin and amphotericin B did not result in antagonism; rather, additive or synergistic effects were seen. Future preclinical work with other echinocandin and polyene derivatives should include studies evaluating the in vivo interactions of both classes of compounds.
机译:已经研究了在传播的念珠菌病的小鼠模型中,echinocandin抗真菌剂西洛芬净和多烯衍生物两性霉素B的体内相互作用。虽然单独使用任何一种药物的单一疗法都能延长感染小鼠的存活时间,但肾菌落计数却没有明显降低。相反,联合疗法,尤其是在两种药物的剂量更高时,会显着延长生存期并抑制肾脏中酵母细胞的生长。实验性念珠菌病与西洛芬净和两性霉素B联合治疗不会产生拮抗作用。而是看到了累加或协同作用。未来与其他棘皮菌素和多烯衍生物的临床前研究应包括评估这两类化合物在体内相互作用的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号